Literature DB >> 30182181

A rare clinical presentation: a pleomorphic xanthoastrocytoma presenting with intracerebral haemorrhage and metastasizing vigorously-case report and review of the literature.

Gülden Demirci Otluoğlu1, M Memet Özek2.   

Abstract

Metastasis of an intracranial tumour is not a common situation in our daily neurosurgical practice. Pleomorphic xanthoastrocytoma is also a rare glial tumour with relatively a favourable prognosis among other CNS pathologies. Here, we present an anaplastic pleomorphic xanthoastrocytoma case which shows both haematogenous and lymphatic metastasis which is described first time in the up-to-date literature. Our case is a 17-year-old male operated for a right occipital intra-axial lesion with a diagnosis of anaplastic pleomorphic xanthoastrocytoma which recurs 5 years later and metastasize vigorously through haematogenous and lymphatic routes. A rare-presenting symptom for this pathology is also intracerebral haemorrhage. This is the ninth case report in the literature which presents initially with this entity.

Entities:  

Keywords:  Anaplastic PXA; Haemorrhage; Lesion; Pleomorphic xanthoastrocytoma

Year:  2018        PMID: 30182181     DOI: 10.1007/s00381-018-3960-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  44 in total

1.  Pleomorphic xanthoastrocytoma: what do we really know about it?

Authors:  C Giannini; B W Scheithauer; P C Burger; D J Brat; P C Wollan; B Lach; B P O'Neill
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

2.  Pleomorphic xanthoastrocytoma with malignant transformation and multiple recurrences in an Iranian girl.

Authors:  Fariba Binesh; Ali Akhavan; Hossein Navabii
Journal:  BMJ Case Rep       Date:  2012-03-20

3.  Cerebromeningeal pleomorphic xanthoastrocytoma. Report on four cases: clinical, radiologic and pathological features. (Including a case with malignant evolution).

Authors:  A Allegranza; S Ferraresi; M Bruzzone; S Giombini
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

4.  Pleomorphic xanthoastrocytoma presenting with massive intracranial hemorrhage.

Authors:  R A Levy; R Allen; P McKeever
Journal:  AJNR Am J Neuroradiol       Date:  1996-01       Impact factor: 3.825

5.  Glioblastoma multiforme masquerading as a pleomorphic xanthoastrocytoma.

Authors:  S J Gaskill; A E Marlin; V Saldivar
Journal:  Childs Nerv Syst       Date:  1988-08       Impact factor: 1.475

6.  Malignant transformation of pleomorphic xanthoastrocytoma.

Authors:  T Nakajima; T Kumabe; H Shamoto; M Watanabe; H Suzuki; T Tominaga
Journal:  Acta Neurochir (Wien)       Date:  2005-06-03       Impact factor: 2.216

7.  Malignant progression of a pleomorphic xanthoastrocytoma in a child.

Authors:  G A Alexiou; M Moschovi; K Stefanaki; C Prodromou; G Sfakianos; N Prodromou
Journal:  Neuropediatrics       Date:  2010-08-26       Impact factor: 1.947

8.  A 28-year-old man with headache, visual and aphasic speech disturbances.

Authors:  Stephan Frank; Dominik Cordier; Markus Tolnay; Marc K Rosenblum
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

9.  Pleomorphic xanthoastrocytoma associated with von Recklinghausen neurofibromatosis.

Authors:  M M Ozek; A Sav; M N Pamir; A F Ozer; E Ozek; C Erzen
Journal:  Childs Nerv Syst       Date:  1993-02       Impact factor: 1.475

10.  Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.

Authors:  Stephanie M Perkins; Nandita Mitra; Wan Fei; Eric T Shinohara
Journal:  J Neurooncol       Date:  2012-07-28       Impact factor: 4.130

View more
  1 in total

Review 1.  Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature.

Authors:  Beatrice Detti; Silvia Scoccianti; Virginia Maragna; Sara Lucidi; Michele Ganovelli; Maria Ausilia Teriaca; Saverio Caini; Isacco Desideri; Benedetta Agresti; Daniela Greto; Anna Maria Buccoliero; Alessandro Della Puppa; Iacopo Sardi; Lorenzo Livi
Journal:  Radiol Med       Date:  2022-08-11       Impact factor: 6.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.